Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors), TUT4 inhibitors(terminal uridylyl transferase 4 inhibitors), TUT7 inhibitors(terminal uridylyl transferase 7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Redona Therapeutics, Inc.Startup |
Active Organization Redona Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult Acute Myeloblastic Leukemia | Preclinical | US | Redona Therapeutics, Inc.Startup | 16 Apr 2023 |